Hattingh Inc, 44115 Woodridge Pkwy, Leesburg, VA 20176, US

Cary Pharmaceuticals is a pharmaceutical development company based in Great Falls, VA. Led by an experienced management team and Board of Directors, the company is focused on advancing the development of QuitPak, a patented treatment for smoking cessation, and a novel catheter lock solution to prevent clot formation in catheters. The company's President, Douglas Cary, brings his expertise from Abbott Laboratories, while Carl Schwan, the CFO, has successfully led two initial public offerings that raised $80 million. Additionally, Lester Crawford, a former Commissioner of the U.S. Food and Drug Administration (FDA), serves as a Director. With its dedication to innovation and a strong leadership team, Cary Pharmaceuticals is poised to make significant contributions to the pharmaceutical industry.Generated from the website

Lea III, William T DDS

Suketu I Patel, MD - Institute of Facial & Oral Surgery

David K Moose, MD - Institute of Facial & Oral Surgery

Inst of Facial